Dublin, April 10, 2026 (GLOBE NEWSWIRE) -- The "Signal Detection: A Comprehensive Introduction (July 1, 2026)" training has been added to ResearchAndMarkets.com's offering.
This comprehensive one-day course provides an in-depth introduction to signal detection in pharmacovigilance
Participants will explore the history, regulatory requirements, and practical processes involved in detecting, validating, and acting upon safety signals. Through expert-led discussions and real-world case studies, attendees will gain a foundational understanding of how signal detection supports patient safety and regulatory compliance.
Who Should Attend: Professionals working within these industries, who want a comprehensive introduction, will benefit from this engaging course:
- Clinical
- Pharmacovigilance
- Regulatory
Key Topics Covered:
- The history of signal detection
- Regulatory requirements for signal detection
- Regulatory expectations (post-marketing for signal detection)
- Signal detection process
- From signal to labelling
Speakers
Graeme Ladds
Graeme is Director of PharSafer and has over 30 years' experience working in the pharmaceutical industry, having started his career at Ashbourne Pharmaceuticals as Head of Drug Safety and Medical Information. Graham has a wealth of experience establishing pharmacovigilance within companies.
For more information about this training visit https://www.researchandmarkets.com/r/eg2kwe
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
